top of page
Developing a safe, convenient, disease-modifying treatment for everyone with peanut allergy.
Aravax is a clinical-stage biotechnology company developing the first safe, convenient and disease-modifying treatment for peanut allergy
PVX108
PVX108
About Us
Aravax is a clinical-stage biotechnology company developing the first safe, convenient and disease-modifying treatment for peanut allergy.
Aravax uses proprietary platform technology to precisely reset the immune system to tolerate allergens, without provoking severe reactions during treatment
bottom of page